SciFluor Life Sciences, LLC – Product Pipeline Review

Global Markets Direct’s, ‘SciFluor Life Sciences, LLC – Product Pipeline Review – 2016’, provides an overview of the SciFluor Life Sciences, LLC’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by SciFluor Life Sciences, LLC, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of SciFluor Life Sciences, LLC

The report provides overview of SciFluor Life Sciences, LLC including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses SciFluor Life Sciences, LLC’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features SciFluor Life Sciences, LLC’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate SciFluor Life Sciences, LLC’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for SciFluor Life Sciences, LLC

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding SciFluor Life Sciences, LLC’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

SciFluor Life Sciences, LLC Snapshot 5

SciFluor Life Sciences, LLC Overview 5

Key Facts 5

SciFluor Life Sciences, LLC - Research and Development Overview 6

Key Therapeutic Areas 6

SciFluor Life Sciences, LLC - Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products - Monotherapy 9

SciFluor Life Sciences, LLC - Pipeline Products Glance 10

SciFluor Life Sciences, LLC - Clinical Stage Pipeline Products 10

Phase II Products/Combination Treatment Modalities 10

SciFluor Life Sciences, LLC - Early Stage Pipeline Products 11

Preclinical Products/Combination Treatment Modalities 11

Discovery Products/Combination Treatment Modalities 12

SciFluor Life Sciences, LLC - Drug Profiles 13

SF-0034 - Drug Profile 13

Product Description 13

Mechanism Of Action 13

R&D Progress 13

SF-0166 - Drug Profile 15

Product Description 15

Mechanism Of Action 15

R&D Progress 15

Small Molecule for Dyskinesia - Drug Profile 16

Product Description 16

Mechanism Of Action 16

R&D Progress 16

Small Molecule for Fibrosis - Drug Profile 17

Product Description 17

Mechanism Of Action 17

R&D Progress 17

Small Molecule for Fungal Infections - Drug Profile 18

Product Description 18

Mechanism Of Action 18

R&D Progress 18

Small Molecule for Infectious Diseases - Drug Profile 19

Product Description 19

Mechanism Of Action 19

R&D Progress 19

Small Molecule for Inflammatory Diseases - Drug Profile 20

Product Description 20

Mechanism Of Action 20

R&D Progress 20

Small Molecule for Neuroinflammation - Drug Profile 21

Product Description 21

Mechanism Of Action 21

R&D Progress 21

Small Molecule for Oncology - Drug Profile 22

Product Description 22

Mechanism Of Action 22

R&D Progress 22

Small Molecule for Pain - Drug Profile 23

Product Description 23

Mechanism Of Action 23

R&D Progress 23

Small Molecule for Spasticity - Drug Profile 24

Product Description 24

Mechanism Of Action 24

R&D Progress 24

SciFluor Life Sciences, LLC - Pipeline Analysis 25

SciFluor Life Sciences, LLC - Pipeline Products by Target 25

SciFluor Life Sciences, LLC - Pipeline Products by Route of Administration 26

SciFluor Life Sciences, LLC - Pipeline Products by Molecule Type 27

SciFluor Life Sciences, LLC - Pipeline Products by Mechanism of Action 28

SciFluor Life Sciences, LLC - Dormant Projects 29

SciFluor Life Sciences, LLC - Locations And Subsidiaries 30

Head Office 30

Appendix 31

Methodology 31

Coverage 31

Secondary Research 31

Primary Research 31

Expert Panel Validation 31

Contact Us 31

Disclaimer 32

List of Tables

List of Tables

SciFluor Life Sciences, LLC, Key Facts 5

SciFluor Life Sciences, LLC – Pipeline by Indication, 2016 7

SciFluor Life Sciences, LLC – Pipeline by Stage of Development, 2016 8

SciFluor Life Sciences, LLC – Monotherapy Products in Pipeline, 2016 9

SciFluor Life Sciences, LLC – Phase II, 2016 10

SciFluor Life Sciences, LLC – Preclinical, 2016 11

SciFluor Life Sciences, LLC – Discovery, 2016 12

SciFluor Life Sciences, LLC – Pipeline by Target, 2016 25

SciFluor Life Sciences, LLC – Pipeline by Route of Administration, 2016 26

SciFluor Life Sciences, LLC – Pipeline by Molecule Type, 2016 27

SciFluor Life Sciences, LLC – Pipeline Products by Mechanism of Action, 2016 28

SciFluor Life Sciences, LLC – Dormant Developmental Projects,2016 29

List of Figures

List of Figures

SciFluor Life Sciences, LLC – Pipeline by Top 10 Indication, 2016 7

SciFluor Life Sciences, LLC – Pipeline by Stage of Development, 2016 8

SciFluor Life Sciences, LLC – Monotherapy Products in Pipeline, 2016 9

SciFluor Life Sciences, LLC – Pipeline by Target, 2016 25

SciFluor Life Sciences, LLC – Pipeline by Molecule Type, 2016 27

SciFluor Life Sciences, LLC – Pipeline Products by Mechanism of Action, 2016 28

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2960

Saved reports